David Sidransky - 15 Oct 2021 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Role: Director
Signature: /s/ David Sidransky
Issuer symbol: CSBR
Transactions as of: 15 Oct 2021
Net transactions value: +$53,001
Form type: 4
Filing time: 19 Oct 2021, 15:39:48 UTC
Previous filing: 14 Jun 2021
Next filing: 04 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSBR	Common Stock	Options Exercise	$26,501	+16,667	+2.2%	$1.59	764,901	15 Oct 2021	Direct
transaction	CSBR	Common Stock	Tax liability	$26,500	+2,629	+0.35%	$10.08	762,272	15 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSBR	Option to purchase Common Stock	Award	$0	+16,667		$0.000000^*	0	15 Oct 2021	Common Stock	16,667	$1.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a "net exercise" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 15, 2021.
F2	The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively.